OS THERAPIES INCORPORATED (OSTX) ROE
- 2026-06-30: ROE 330.43%.
- 2026-03-31: ROE 325.88%.
- 2025-12-31: ROE 471.71%.
- 2025-09-30: ROE -502.70%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 330.43% |
| 2026-03-31 | 325.88% |
| 2025-12-31 | 471.71% |
| 2025-09-30 | -502.70% |
| 2025-06-30 | -288.85% |
| 2025-03-31 | 269.93% |
| 2024-12-31 | 271.94% |
| 2024-09-30 | 1040.30% |
| 2024-06-30 | 23.85% |
| 2024-03-31 | 29.03% |
| 2023-12-31 | 32.44% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | 471.71% |
| 2024-12-31 | 271.94% |
| 2023-12-31 | 32.44% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |